[1] Prince MJ, Wu F, Guo Y, et al. The burden of disease in older people and implications for health policy and practice. Lancet 2015; 385: 549−562. doi: 10.1016/S0140-6736(14)61347-7 [2] Jung YJ, Yoon JL, Kim HS, et al. Atypical clinical presentation of geriatric syndrome in elderly patients with pneumonia or coronary artery disease. Ann Geriatr Med Res 2017; 21: 158−163. doi: 10.4235/agmr.2017.21.4.158 [3] Tyrrell DJ, Goldstein DR. Ageing and atherosclerosis: vascular intrinsic and extrinsic factors and potential role of IL-6. Nat Rev Cardiol 2021; 18: 58−68. doi: 10.1038/s41569-020-0431-7 [4] Dutta P, Courties G, Wei Y, et al. Myocardial infarction accelerates atherosclerosis. Nature 2012; 487: 325−329. doi: 10.1038/nature11260 [5] Budzianowski J, Pieszko K, Burchardt P, et al. The role of hematological indices in patients with acute coronary syndrome. Dis Markers 2017; 2017: 3041565. doi: 10.1155/2017/3041565 [6] Li W, Liu Q, Tang Y. Platelet to lymphocyte ratio in the prediction of adverse outcomes after acute coronary syndrome: a meta-analysis. Sci Rep 2017; 7: 40426. doi: 10.1038/srep40426 [7] Kurtul A, Murat SN, Yarlioglues M, et al. Association of platelet-to-lymphocyte ratio with severity and complexity of coronary artery disease in patients with acute coronary syndromes. Am J Cardiol 2014; 114: 972−978. doi: 10.1016/j.amjcard.2014.07.005 [8] Avci BŞ, Avci A, Dönmez Y, et al. The effectiveness of neutrophil-lymphocyte ratio in predicting in-hospital mortality in non-ST-elevation myocardial infarction. Emerg Med Int 2020; 2020: 8718304. doi: 10.1155/2020/8718304 [9] Machado GP, Araujo GN, Carpes CK, et al. Comparison of neutrophil-to-lymphocyte ratio and mean platelet volume in the prediction of adverse events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction. Atherosclerosis 2018; 274: 212−217. doi: 10.1016/j.atherosclerosis.2018.05.022 [10] Bajari R, Tak S. Predictive prognostic value of neutrophil-lymphocytes ratio in acute coronary syndrome. Indian Heart J 2017; 69: S46−S50. doi: 10.1016/j.ihj.2017.01.020 [11] Bhat T, Teli S, Rijal J, et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther 2013; 11: 55−59. doi: 10.1586/erc.12.159 [12] Tamhane UU, Aneja S, Montgomery D, et al. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 2008; 102: 653−657. doi: 10.1016/j.amjcard.2008.05.006 [13] Azab B, Zaher M, Weiserbs KF, et al. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol 2010; 106: 470−476. doi: 10.1016/j.amjcard.2010.03.062 [14] Sahin DY, Elbasan Z, Gür M, et al. Neutrophil to lymphocyte ratio is associated with the severity of coronary artery disease in patients with ST-segment elevation myocardial infarction. Angiology 2013; 64: 423−429. doi: 10.1177/0003319712453305 [15] Wang X, Zhang G, Jiang X, et al. Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis of observational studies. Atherosclerosis 2014; 234: 206−213. doi: 10.1016/j.atherosclerosis.2014.03.003 [16] Yaylak B, Ede H, Baysal E, et al. Neutrophil/lymphocyte ratio is associated with right ventricular dysfunction in patients with acute inferior ST-segment elevation myocardial infarction. Cardiol J 2016; 23: 100−106. doi: 10.5603/CJ.a2015.0061 [17] Ayça B, Akın F, Celik O, et al. Neutrophil to lymphocyte ratio is related to stent thrombosis and high mortality in patients with acute myocardial infarction. Angiology 2015; 66: 545−552. doi: 10.1177/0003319714542997 [18] Libby P, Okamoto Y, Rocha VZ, et al. Inflammation in atherosclerosis: transition from theory to practice. Circ J 2010; 74: 213−220. doi: 10.1253/circj.CJ-09-0706 [19] [20] [21] Palasubramaniam J, Wang X, Peter K. Myocardial infarction: from atherosclerosis to thrombosis. Arterioscler Thromb Vasc Biol 2019; 39: e176−e185. doi: 10.1161/ATVBAHA.119.312578 [22] Madjid M, Awan I, Willerson JT, et al. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 2004; 44: 1945−1956. doi: 10.1016/j.jacc.2004.07.056 [23] Chia S, Nagurney JT, Brown DF, et al. Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarction. Am J Cardiol 2009; 103: 333−337. doi: 10.1016/j.amjcard.2008.09.085 [24] Distelmaier K, Winter MP, Dragschitz F, et al. Prognostic value of culprit site neutrophils in acute coronary syndrome. Eur J Clin Invest 2014; 44: 257−265. doi: 10.1111/eci.12228 [25] Major AS, Fazio S, Linton MF. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol 2002; 22: 1892−1898. doi: 10.1161/01.ATV.0000039169.47943.EE [26] Zouridakis EG, Garcia-Moll X, Kaski JC. Usefulness of the blood lymphocyte count in predicting recurrent instability and death in patients with unstable angina pectoris. Am J Cardiol 2000; 86: 449−451. doi: 10.1016/S0002-9149(00)00963-2 [27] Falk E, Nakano M, Bentzon JF, et al. Update on acute coronary syndromes: the pathologists’ view. Eur Heart J 2013; 34: 719−728. doi: 10.1093/eurheartj/ehs411 [28] Nikolsky E, Grines CL, Cox DA, et al. Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial). Am J Cardiol 2007; 99: 1055−1061. doi: 10.1016/j.amjcard.2006.11.066 [29] Azab B, Shah N, Akerman M, et al. Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis 2012; 34: 326−334. doi: 10.1007/s11239-012-0718-6 [30] Sun XP, Li J, Zhu WW, et al. Impact of platelet-to-lymphocyte ratio on clinical outcomes in patients with ST-segment elevation myocardial infarction. Angiology 2017; 68: 346−353. doi: 10.1177/0003319716657258 [31] Acet H, Ertaş F, Akıl MA, et al. Relationship between hematologic indices and Global Registry of Acute Coronary Events risk score in patients with ST-segment elevation myocardial infarction. Clin Appl Thromb Hemost 2016; 22: 60−68. doi: 10.1177/1076029614533145